Frontiers in Psychiatry,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 26, 2024
Explore
the
application
effects
of
"Internet
+"
continuous
emotional
management
training
in
depression
patients
and
analyze
feasibility
innovative
rehabilitation
methods.
Ageing Research Reviews,
Journal Year:
2025,
Volume and Issue:
unknown, P. 102710 - 102710
Published: Feb. 1, 2025
Treatment-resistant
late-life
depression
(TRLLD)
affects
nearly
half
of
older
adults
with
major
depression.
This
systematic
review
evaluates
published
evidence
effectiveness
both
pharmacological
and
non-pharmacological
treatments
for
TRLLD.
A
search
MEDLINE,
EMBASE,
CINAHL,
PsycINFO,
the
Cochrane
Library,
online
trial
registries
up
to
March
2024
was
conducted
identify
randomized
controlled
trials
(RCTs)
evaluating
interventions
Seven
studies
assessed
(antidepressants,
antipsychotics,
mood
stabilizers,
or
ketamine)
another
seven
examined
approaches
(psychotherapy,
electroconvulsive
therapy,
repetitive
transcranial
magnetic
stimulation
(rTMS),
computerized
cognitive
remediation).
Aripiprazole
(2
studies),
venlafaxine
(1
study),
ketamine
lithium
study)
were
associated
a
reduction
in
depressive
symptoms
post-treatment
compared
comparator
treatment
group.
rTMS
sequential
bilateral
theta
burst
remediation
also
showed
significant
improvements
Quality
varied
from
very
low
medium
among
included
studies.
Most
reported
data
on
small
sample
sizes.
We
identified
number
RCTs
augmentation
appears
be
an
effective
based
two
studies,
acceptable
side
effect
profile.
Other
may
effective,
but
is
low-quality
evidence.
Future
large-scale
are
urgently
needed
draw
firm
conclusions.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: June 25, 2024
Depression,
projected
to
be
the
predominant
contributor
global
disease
burden,
is
a
complex
condition
with
diverse
symptoms
including
mood
disturbances
and
cognitive
impairments.
Traditional
treatments
such
as
medication
psychotherapy
often
fall
short,
prompting
pursuit
of
alternative
interventions.
Recent
research
has
highlighted
significant
role
gut
microbiota
in
mental
health,
influencing
emotional
neural
regulation.
Fecal
transplantation
(FMT),
infusion
fecal
matter
from
healthy
donor
into
patient,
emerges
promising
strategy
ameliorate
depressive
by
restoring
microbial
balance.
The
microbial-gut-brain
(MGB)
axis
represents
critical
pathway
through
which
potentially
rectify
dysbiosis
modulate
neuropsychiatric
outcomes.
Preclinical
studies
reveal
that
FMT
can
enhance
neurochemicals
reduce
inflammatory
markers,
thereby
alleviating
behaviors.
Moreover,
shown
promise
clinical
settings,
improving
gastrointestinal
overall
quality
life
patients
depression.
review
highlights
gut-brain
depression
need
for
further
validate
long-term
safety
efficacy
FMT,
identify
specific
therapeutic
strains,
develop
targeted
modulation
strategies.
Advancing
our
understanding
could
revolutionize
treatment,
shifting
paradigm
toward
microbiome-targeting
therapies.
Brain and Behavior,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 1, 2025
ABSTRACT
Background
In
recent
years,
cognitive
impairment
has
emerged
as
a
pivotal
symptom
in
elderly
patients
with
depression,
exerting
substantial
impact
on
the
course
and
prognosis
of
diseases.
Moreover,
it
persists
even
following
remission
from
depression
during
rehabilitation
period.
However,
there
remains
an
incomplete
understanding
relevant
influencing
factors
for
depressed
patients,
which
seriously
impedes
development
risk
prediction
models
subsequent
research
precision
intervention
programs.
Objective
The
purpose
this
study
is
to
examine
current
state
negative
assessment
tools
late‐life
(LLD),
thereby
providing
theoretical
framework
construction
targeted
Methods
search
strategy
employed
followed
evidence‐based
approach,
utilizing
systematic
scoping
review
thoroughly
explore
six
English
four
Chinese
databases
up
until
November
2023.
Two
researchers
independently
conducted
article
screening
thematic
analysis
categorize
results
into
themes.
Results
Following
two
rounds
rigorous
by
team,
data
were
meticulously
extracted
succinctly
summarized
five
distinct
themes
encompassing
socio‐demographic,
physiological,
psychological,
genetic,
other
related
factors.
addition,
comprehensive
compilation
19
diverse
was
undertaken.
Ultimately,
total
22
articles
met
eligibility
criteria
inclusion
study.
These
comprised
longitudinal
studies,
nine
pathological
controlled
cross‐sectional
cohort
one
randomized
Conclusion
Cognitive
dysfunction
important
LLD,
affects
survival
patients.
At
present,
its
mainly
includes
There
have
been
existing
function
specifically
those
18‐
65‐year‐old
major
depressive
disorder,
but
still
lack
reliability
validity
tests
LLD.
BMC Geriatrics,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 28, 2025
Globally,
falls
are
considered
a
serious
healthcare
problem
for
aged
care
residents.
Fall-risk-increasing
drugs
(FRIDs)
medications
that
can
increase
the
risk
of
falling,
given
their
adverse
effects.
Medication
reviews
advocated
to
identify
potentially
inappropriate
use
FRIDs.
However,
impact
on
clinical
and
resident-centered
outcomes
is
unclear.
This
study
explored
residents'
FRIDs
content
medication
review
reports
concerning
these.
A
retrospective
cross-sectional
completed
between
1st
July
2021
30th
June
2022
was
conducted.
Statistical
descriptive
analysis
used
examine
(defined
as
listed
in
Screening
Tool
Older
Persons
Prescriptions
older
adults
with
high
fall
(STOPPFall)).
The
resident's
medicine
experience,
identified
drug-related
problems
(DRPs),
related
recommendations
were
via
analysis.
For
deprescribe
FRIDs,
situations
detailed
compared
those
presented
STOPPFall.
relating
966
residents
analysed.
Of
these
residents,
83.2%
(n
=
804)
31.2%
301)
taking
three
or
more
In
total,
pharmacists
made
2635
DRPs,
which
19.7%
520)
deprescribing
recommended.
situation
most
frequently
recommended
FRID
an
indication
limited
benefit
37.9%
197).
not
130
(25.0%)
only
included
viewpoint
deprescribing.
found
be
highly
prevalent
among
Pharmacists
opportunities
often
omitted
resident
viewpoints
grounds
Using
communication
could
improve
outcomes.
Medicina,
Journal Year:
2025,
Volume and Issue:
61(2), P. 257 - 257
Published: Feb. 2, 2025
Background
and
Objectives:
Depression
is
a
common
mental
problem
in
the
older
population
has
significant
impact
on
recovery
general
well-being.
A
comprehensive
understanding
of
prevalence
depressive
symptoms
their
effects
functional
outcomes
essential
for
improving
care
strategies.
The
primary
aim
this
study
was
to
determine
patients
undergoing
geriatric
rehabilitation
assess
specific
abilities.
Materials
Methods:
retrospective
conducted
at
Lucerne
Cantonal
Hospital
Wolhusen,
Switzerland,
spanning
from
2015
2020
including
1159
individuals
aged
65
years
older.
presence
assessed
using
Geriatric
Scale
(GDS)
Short
Form,
while
abilities
were
evaluated
Functional
Independence
Measure
(FIM)
Tinetti
test.
Data
analysis
performed
TIBCO
Statistica
13.3,
with
statistical
significance
set
p
<
0.05.
Results:
Of
participants,
22.9%
(N
=
266)
exhibited
symptoms,
no
notable
differences
between
genders.
Although
all
showed
improvements,
duration
prolonged
by
two
days
(p
0.012,
d
0.34)
those
symptoms.
Alarmingly,
76%
participants
classified
as
risk
falling
based
score.
However,
correlation
found
GDS
scores
admission
0.835,
r
0.211)
or
discharge
0.336,
0.184).
results
non-parametric
Wilcoxon
matched-pairs
test
provide
compelling
evidence
changes
FIM
when
comparing
across
categories.
Conclusions:
Depressive
are
particularly
patients,
leading
time
increased
healthcare
costs.
While
mobility
impairments,
improvements
status
directly
associated
reduced
scores.
Considering
health
during
planning
critical
optimizing
outcomes.
Reviews in the Neurosciences,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 13, 2025
Abstract
Major
depressive
disorder
is
a
common
mental
disorder,
and
significant
number
of
patients
exhibit
poor
response
to
conventional
antidepressant
treatments,
known
as
treatment-resistant
depression
(TRD).
However,
the
definition
TRD
globally
remains
unclear,
impeding
clinical
research,
treatment
development,
outcome
implementation,
policy-making.
A
wealth
research
confirms
that
rTMS
demonstrates
promising
efficacy
in
TRD.
This
paper
elucidates
TRD,
summarizes
potential
targets
for
treating
comprehensively
elaborates
on
unique
mechanisms,
efficacy,
side
effects
outlines
considerations
special
populations
receiving
well
other
modalities
Through
these
studies,
we
aim
provide
more
scientifically
grounded
recommendations
undergoing